Moreover, in patients with T1DM, complement C3 incorporation into clots is reportedly enhanced [21], plasminogen is glycated and leads to reduced plasmin generation and impaired protein activity [22], these result in hypofibrinolysis. This evidence concerns the gene PLG and type 1 diabetes mellitus.